Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Synchronous identification of a dysembryoplastic neuroepithelial tumor (DNET) and an oligodendroglioma in a patient: A case report.

Ravanpay AC, Gabikian P, Marshall D, Williams JR, Huber B, Silbergeld DL.

Clin Neuropathol. 2019 Jul 2. doi: 10.5414/NP301178. [Epub ahead of print]

PMID:
31262396
2.

Patterns of Failure After Stereotactic Radiosurgery for Recurrent High-Grade Glioma: A Single Institution Experience of 10 Years.

Ene CI, Macomber MW, Barber JK, Ferreira MJ, Ellenbogen RG, Holland EC, Rockhill JK, Silbergeld DL, Halasz LM.

Neurosurgery. 2019 Aug 1;85(2):E322-E331. doi: 10.1093/neuros/nyy520.

PMID:
30576476
3.

h-Channels Contribute to Divergent Intrinsic Membrane Properties of Supragranular Pyramidal Neurons in Human versus Mouse Cerebral Cortex.

Kalmbach BE, Buchin A, Long B, Close J, Nandi A, Miller JA, Bakken TE, Hodge RD, Chong P, de Frates R, Dai K, Maltzer Z, Nicovich PR, Keene CD, Silbergeld DL, Gwinn RP, Cobbs C, Ko AL, Ojemann JG, Koch C, Anastassiou CA, Lein ES, Ting JT.

Neuron. 2018 Dec 5;100(5):1194-1208.e5. doi: 10.1016/j.neuron.2018.10.012. Epub 2018 Nov 1.

PMID:
30392798
4.

Sparse recurrent excitatory connectivity in the microcircuit of the adult mouse and human cortex.

Seeman SC, Campagnola L, Davoudian PA, Hoggarth A, Hage TA, Bosma-Moody A, Baker CA, Lee JH, Mihalas S, Teeter C, Ko AL, Ojemann JG, Gwinn RP, Silbergeld DL, Cobbs C, Phillips J, Lein E, Murphy G, Koch C, Zeng H, Jarsky T.

Elife. 2018 Sep 26;7. pii: e37349. doi: 10.7554/eLife.37349.

5.

Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.

Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H, Bruce JN, Butler W, Cahill DP, Carter B, Orringer DA, Roberts DW, Sagher O, Sanai N, Schwartz TH, Silbergeld DL, Sisti MB, Thompson RC, Waziri AE, Ghogawala Z, McKhann G 2nd.

Neurosurgery. 2017 Apr 1;80(4):590-601. doi: 10.1227/NEU.0000000000001374. Erratum in: Neurosurgery. 2018 May 1;82(5):749.

6.

Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors.

Ene CI, Nerva JD, Morton RP, Barkley AS, Barber JK, Ko AL, Silbergeld DL.

Surg Neurol Int. 2016 May 6;7(Suppl 11):S295-9. doi: 10.4103/2152-7806.181987. eCollection 2016.

7.

Flow-Related Aneurysm within Glioblastoma: A Case Report and Review of Literature.

Ene CI, Nerva JD, McGrath L, Flanagan ME, Chamberlain MC, Silbergeld DL.

World Neurosurg. 2016 May;89:729.e1-6. doi: 10.1016/j.wneu.2016.01.068. Epub 2016 Feb 4. Review.

PMID:
26851739
8.

Recurrent Supplementary Motor Area Syndrome Following Repeat Brain Tumor Resection Involving Supplementary Motor Cortex.

Abel TJ, Buckley RT, Morton RP, Gabikian P, Silbergeld DL.

Neurosurgery. 2015 Sep;11 Suppl 3:447-55; discussion 456. doi: 10.1227/NEU.0000000000000847.

9.

Treatment of Gliomas: How did we get here?

Chowdhary MM, Ene CI, Silbergeld DL.

Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S85-8. doi: 10.4103/2152-7806.151348. eCollection 2015.

10.

Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes.

Kumar A, Boyle EA, Tokita M, Mikheev AM, Sanger MC, Girard E, Silber JR, Gonzalez-Cuyar LF, Hiatt JB, Adey A, Lee C, Kitzman JO, Born DE, Silbergeld DL, Olson JM, Rostomily RC, Shendure J.

Genome Biol. 2014 Dec 3;15(12):530. doi: 10.1186/s13059-014-0530-z.

11.

O6-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with MGMT promoter methylation in glioblastoma and anaplastic glioma.

Bobola MS, Alnoor M, Chen JY, Kolstoe DD, Silbergeld DL, Rostomily RC, Blank A, Chamberlain MC, Silber JR.

BBA Clin. 2015 Jun 1;3:1-10.

12.

Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.

Baldock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, Lai A, Cloughesy T, McKhann GM 2nd, Bruce JN, Rostomily RC, Canoll P, Swanson KR.

PLoS One. 2014 Oct 28;9(10):e99057. doi: 10.1371/journal.pone.0099057. eCollection 2014.

13.

Operative cytoreduction for recurrent glioblastoma.

Morton RP, Nerva JD, Abecassis IJ, Silbergeld DL, Kim LJ.

World Neurosurg. 2014 Dec;82(6):929-31. doi: 10.1016/j.wneu.2014.10.004. Epub 2014 Oct 13. No abstract available.

PMID:
25311979
14.

Predicting prognosis of brain metastasis using molecular and clinical variables.

Ene CI, Silbergeld DL.

World Neurosurg. 2015 Apr;83(4):490-1. doi: 10.1016/j.wneu.2014.09.009. Epub 2014 Sep 16. No abstract available.

PMID:
25219584
15.

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC, Storer BE, Rockhill JK, Swanson KR, Kiem HP.

J Clin Invest. 2014 Sep;124(9):4082-92. doi: 10.1172/JCI76739. Epub 2014 Aug 8.

16.

Controversies in the management of brain metastases.

Levitt MR, Levitt R, Silbergeld DL.

Surg Neurol Int. 2013 May 2;4(Suppl 4):S231-5. doi: 10.4103/2152-7806.111300. Print 2013.

17.

Cerebral metastatic disease: applying what we know to rare brain metastases.

Celix JM, Silbergeld DL.

World Neurosurg. 2014 Jan;81(1):50-1. doi: 10.1016/j.wneu.2013.03.061. Epub 2013 Mar 27. No abstract available.

PMID:
23542387
18.

Safety and efficacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma.

Ko AL, Fink KR, Stelzer KM, Silbergeld DL.

Surg Neurol Int. 2012;3:137. doi: 10.4103/2152-7806.103644. Epub 2012 Nov 20.

19.

Famous face identification in temporal lobe epilepsy: support for a multimodal integration model of semantic memory.

Drane DL, Ojemann JG, Phatak V, Loring DW, Gross RE, Hebb AO, Silbergeld DL, Miller JW, Voets NL, Saindane AM, Barsalou L, Meador KJ, Ojemann GA, Tranel D.

Cortex. 2013 Jun;49(6):1648-67. doi: 10.1016/j.cortex.2012.08.009. Epub 2012 Sep 5.

20.

Cortical stimulation mapping and Wada results demonstrate a normal variant of right hemisphere language organization.

Drane DL, Roraback-Carson J, Hebb AO, Hersonskey T, Lucas T, Ojemann GA, Lettich E, Silbergeld DL, Miller JW, Ojemann JG.

Epilepsia. 2012 Oct;53(10):1790-8. doi: 10.1111/j.1528-1167.2012.03573.x. Epub 2012 Jul 10.

21.

Is graded prognostic assessment an improvement compared with radiation therapy oncology group's recursive partitioning analysis classification for brain metastases?

Chamberlain MC, Silbergeld DL.

J Clin Oncol. 2012 Sep 10;30(26):3315-6; author reply 3316-7. doi: 10.1200/JCO.2012.42.6429. Epub 2012 May 29. No abstract available.

PMID:
22649127
22.

Radiation associated tumors following therapeutic cranial radiation.

Chowdhary A, Spence AM, Sales L, Rostomily RC, Rockhill JK, Silbergeld DL.

Surg Neurol Int. 2012;3:48. doi: 10.4103/2152-7806.96068. Epub 2012 May 14.

23.

Extended survival of glioblastoma patients after chemoprotective HSC gene therapy.

Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL, Mrugala MM, Kiem HP.

Sci Transl Med. 2012 May 9;4(133):133ra57. doi: 10.1126/scitranslmed.3003425.

24.

Surgery, a prognostic marker for progression-free survival?

Chamberlain MC, Silbergeld DL.

Neuro Oncol. 2012 Apr;14(4):390-1; author reply 391. doi: 10.1093/neuonc/nos057. No abstract available.

25.

The sub-pial resection technique for intrinsic tumor surgery.

Hebb AO, Yang T, Silbergeld DL.

Surg Neurol Int. 2011;2:180. doi: 10.4103/2152-7806.90714. Epub 2011 Dec 13.

26.

Propionibacterium acnes osteomyelitis occurring 23 years after craniotomy: case report and review of literature.

Levitt MR, Gabikian P, Pottinger PS, Silbergeld DL.

Neurosurgery. 2011 Sep;69(3):E773-9; discussion E779. doi: 10.1227/NEU.0b013e31821964ba.

PMID:
21471838
27.

Vaginal allodynia as the presentation of a thalamic tumor.

Silbergeld DL, Hebb AO, Loeser JD.

Pain. 2011 Mar;152(3):698-702. doi: 10.1016/j.pain.2010.12.021. Epub 2011 Jan 22.

PMID:
21257264
28.

Parahippocampal corpora amylacea: case report.

Abel TJ, Hebb AO, Keene CD, Born DE, Silbergeld DL.

Neurosurgery. 2010 Jun;66(6):E1206-7. doi: 10.1227/01.NEU.0000369196.94664.4E.

PMID:
20495392
29.

Cortical stimulation mapping in a patient with foreign accent syndrome: case report.

Abel TJ, Hebb AO, Silbergeld DL.

Clin Neurol Neurosurg. 2009 Jan;111(1):97-101. doi: 10.1016/j.clineuro.2008.07.014. Epub 2008 Oct 19.

PMID:
18938026
30.

Category-specific recognition and naming deficits following resection of a right anterior temporal lobe tumor in a patient with atypical language lateralization.

Drane DL, Ojemann GA, Ojemann JG, Aylward E, Silbergeld DL, Miller JW, Tranel D.

Cortex. 2009 May;45(5):630-40. doi: 10.1016/j.cortex.2008.04.007. Epub 2008 Jun 5.

31.

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.

Spence AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC, Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA.

Clin Cancer Res. 2008 May 1;14(9):2623-30. doi: 10.1158/1078-0432.CCR-07-4995.

32.

Category-specific naming and recognition deficits in temporal lobe epilepsy surgical patients.

Drane DL, Ojemann GA, Aylward E, Ojemann JG, Johnson LC, Silbergeld DL, Miller JW, Tranel D.

Neuropsychologia. 2008 Apr;46(5):1242-55. doi: 10.1016/j.neuropsychologia.2007.11.034. Epub 2007 Dec 15.

33.

Positron emission tomography-guided conformal fast neutron therapy for glioblastoma multiforme.

Stelzer KJ, Douglas JG, Mankoff DA, Silbergeld DL, Krohn KA, Laramore GE, Spence AM.

Neuro Oncol. 2008 Feb;10(1):88-92. Epub 2007 Nov 30.

34.
35.

Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.

Rostomily RC, Elias M, Deng M, Elias P, Born DE, Muballe D, Silbergeld DL, Futran N, Weymuller EA, Mankoff DA, Eary J.

Head Neck. 2006 Apr;28(4):305-12.

PMID:
16470879
36.

[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.

Douglas JG, Stelzer KJ, Mankoff DA, Tralins KS, Krohn KA, Muzi M, Silbergeld DL, Rostomily RC, Scharnhorst J, Spence AM.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):886-91. Epub 2005 Oct 19.

PMID:
16242251
37.

TWIST is expressed in human gliomas and promotes invasion.

Elias MC, Tozer KR, Silber JR, Mikheeva S, Deng M, Morrison RS, Manning TC, Silbergeld DL, Glackin CA, Reh TA, Rostomily RC.

Neoplasia. 2005 Sep;7(9):824-37.

38.

Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.

Mourad PD, Farrell L, Stamps LD, Chicoine MR, Silbergeld DL.

Surg Neurol. 2005 Jun;63(6):511-9; discussion 519.

PMID:
15936366
39.

Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy.

Bobola MS, Emond MJ, Blank A, Meade EH, Kolstoe DD, Berger MS, Rostomily RC, Silbergeld DL, Spence AM, Silber JR.

Clin Cancer Res. 2004 Dec 1;10(23):7875-83.

40.

Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas.

Spence AM, Peterson RA, Scharnhorst JD, Silbergeld DL, Rostomily RC.

J Neurooncol. 2004 Oct;70(1):91-5.

PMID:
15527114
41.

Gamma knife stereotactic radiosurgical boost for patients treated primarily with neutron radiotherapy for salivary gland neoplasms.

Douglas JG, Silbergeld DL, Laramore GE.

Stereotact Funct Neurosurg. 2004;82(2-3):84-9. Epub 2004 Mar 25.

PMID:
15305080
42.

Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes.

Holmes MD, Silbergeld DL, Drouhard D, Wilensky AJ, Ojemann LM.

Seizure. 2004 Jul;13(5):340-5.

43.

The effects of hydrogen peroxide on brain and brain tumors.

Mesiwala AH, Farrell L, Santiago P, Ghatan S, Silbergeld DL.

Surg Neurol. 2003 May;59(5):398-407; discussion 407.

PMID:
12765817
44.

Quantitative assessment of glioblastoma invasion in vivo.

Mourad PD, Farrell L, Stamps LD, Santiago P, Fillmore HL, Broaddus WC, Silbergeld DL.

Cancer Lett. 2003 Mar 20;192(1):97-107.

PMID:
12637158
45.

Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.

Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomily RC, Hummel S, Scharnhorst J, Krohn KA, Spence AM.

J Nucl Med. 2002 Dec;43(12):1667-73. Erratum in: J Nucl Med. 2003 Oct;44(10):1603. Rostomilly Robert [corrected to Rostomily Robert C].

46.
47.

Resection of glioblastoma.

Silbergeld DL, Rostomily RC.

J Neurosurg. 2002 Apr;96(4):809; author reply 810. No abstract available.

PMID:
11990830
48.

High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo.

Mesiwala AH, Farrell L, Wenzel HJ, Silbergeld DL, Crum LA, Winn HR, Mourad PD.

Ultrasound Med Biol. 2002 Mar;28(3):389-400.

PMID:
11978420
49.

Characterization of the mu rhythm during rapid eye movement sleep.

Duntley SP, Kim AH, Silbergeld DL, Miller JW.

Clin Neurophysiol. 2001 Mar;112(3):528-31.

PMID:
11222975
50.

Spatial spectral analysis of human electrocorticograms including the alpha and gamma bands.

Freeman WJ, Rogers LJ, Holmes MD, Silbergeld DL.

J Neurosci Methods. 2000 Feb 15;95(2):111-21.

PMID:
10752481

Supplemental Content

Loading ...
Support Center